How can symptom assessment apps contribute to early cancer detection?

<p>Presented at AI in Cancer Diagnostics: from research to clinical practice, European Association for Cancer Research (EACR), 2021</p> <ul> <li>Ada has the potential to help surface users who should seek care, including possible early cases and users who do not participate in screening programs</li> <li>Correlations between Ada’s cancer frequency in Germany and the German cancer registry incidence data were statistically significant </li> <li>Between 23% and 94% of Ada assessments where cancer was suggested reported no advanced signs, and between 19% and 41% reported first signs and no advanced signs.</li> </ul>